Acumen Pharmaceuticals

ABOS

Börsenwert 122 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 RA Capital Management Boston, Massachusetts	56,1 Mio. $	–	–	–
2	2 Sands Capital Ventures Arlington, Virginia	9,9 Mio. $	–	–	–
3	3 BlackRock New York	6,65 Mio. $	+5,71 Mio. $	+2.311.789	+1.296 %
4	4 Alyeska Investment Group Chicago, Illinois	6,55 Mio. $	–	–	–
5	5 Franklin Resources San Mateo, California	6,15 Mio. $	–	–	–
6	6 ADAR1 Capital Management Austin, Texas	5,64 Mio. $	-111.164 $	-45.000	-2 %
7	7 Vanguard Capital Management Malvern, Pennsylvania	4,46 Mio. $	+409.563 $	+165.795	+11 %
8	8 Knollwood Investment Advisory Hunt Valley, Maryland	4,35 Mio. $	–	–	–
9	9 Geode Capital Management Boston, Massachusetts	3,05 Mio. $	+1,79 Mio. $	+725.620	+174 %
10	10 Ikarian Capital Dallas, Texas	2,81 Mio. $	–	–	–
11	11 Hudson Bay Capital Management Stamford, Connecticut	2,55 Mio. $	-34.436 $	-13.940	-1 %
12	12 Pathstone Holdings Englewood, New Jersey	2,29 Mio. $	–	–	–
13	13 Renaissance Technologies New York	1,8 Mio. $	+496.725 $	+201.079	+42 %
14	14 Two Sigma Investments New York	1,66 Mio. $	+227.441 $	+92.070	+17 %
15	15 State Street Boston, Massachusetts	1,6 Mio. $	+1,11 Mio. $	+448.800	+296 %
16	16 Northern Trust Chicago, Illinois	963.187 $	+705.350 $	+285.532	+380 %
17	17 Vanguard Portfolio Management Malvern, Pennsylvania	856.523 $	+792.460 $	+320.795	Neu
18	18 Dimensional Fund Advisors Austin, Texas	778.969 $	+424.405 $	+171.803	+143 %
19	19 Vanguard Fiduciary Trust Malvern, Pennsylvania	777.611 $	+227.302 $	+92.014	+46 %
20	20 Bank of America Charlotte, North Carolina	733.665 $	-112.238 $	-45.435	-14 %
21	21 Boothbay Fund Management New York	728.942 $	–	–	–
22	22 Acadian Asset Management Boston, Massachusetts	718.000 $	+208.711 $	+84.488	+45 %
23	23 Nomura Holdings Tokyo, Japan	506.531 $	+468.646 $	+189.712	Neu
24	24 Goldman Sachs New York	491.085 $	-56.214 $	-22.756	-11 %
25	25 Bridgeway Capital Management Houston, Texas	470.377 $	–	–	–

Acumen Pharmaceuticals ABOS Börsenwert 122 Mio. $

Acumen Pharmaceuticals

ABOS

Börsenwert 122 Mio. $